EGFR and cancer: EGFR (Wei et al., 2013; Robichaux et al., 2018) and platium (Vaughn et al., 2009; Teo et al., 2017; Pal et al., 2018) have been reported to be involved in the treatment of cancer, and through these enriched genes we may be able to discover specific mechanisms of drug resistance.